Selective Pulmonary Vasodilator Therapy and Improved Survival in Eisenmenger Syndrome: The ANZ CHD-PAH Registry - 03/08/17
Doi : 10.1016/j.hlc.2017.06.658
C. Arnott 1, 2, ⁎, G. Strange 3, C. O’Donnell 4, A. Bullock 5, D. Radford 6, 8, L. Grigg 7, 9, D. Celermajer 1, 2
1 Royal Prince Alfred Hospital, Sydney, Australia
2 Sydney Medical School, University of Sydney, Sydney, Australia
3 School of Medicine, University of Notre Dame, Sydney, Australia
4 Department of Paediatrics, University of Auckland, Auckland, New Zealand
5 Princess Margaret Hospital for Children, Perth, Australia
6 The Prince Charles Hospital Brisbane, Brisbane, Australia
7 Royal Melbourne Hospital, Melbourne, Australia
8 Department of Medicine, University of Queensland, Brisbane, Australia
9 University of Melbourne, Melbourne, Australia
⁎Corresponding author.
Le texte complet de cet article est disponible en PDF.
© 2017
Publié par Elsevier Masson SAS.
Vol 26 - N° S2
P. S326 - 2017 Retour au numéro
Article précédent
- Partial Anomalous Pulmonary Venous Connection Presenting as Eisenmenger's Syndrome
- H. Thakkar, M. Sebastian
- Surgeries for Adults with Bicuspid Aortic Valve (BAV) in Adults with a Past History of Coarctation Repair–Differences from Isolated BAV Patients
- H. Ainge-Allen, I. Kotchetkova, M. Vallely, P. Bannon, D. Celermajer
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?